AddLife AB Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 4/21/2026)
| Balance Sheet | Total Assets | 12,711,000,000.00 | ROE | 42.82 % |
| Balance Sheet | Total Equity | 5,443,000,000.00 | ROA | 4.41 % |
| Cashflow | Capital Expenditures | -254,000,000.00 | P/FCF | 18.74 |
| Cashflow | Free Cash Flow | 1,138,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,392,000,000.00 | P/CF | 15.32 |
| Income | Earnings per Share (diluted) | 3.62 | Div. Yield | 0.86 % |
| Income | Net Income | 560,000,000.00 | P/E | 38.04 |
| Income | Shares Outstanding | 121,864,000.00 | P/B | 3.92 |
| Income | Total Revenue | 10,442,000,000.00 | P/S | 2.04 |
Ratios calculated on: 10/14/2026
Company Description
AddLife AB (publ), together with its subsidiaries, supplies equipment, instruments, and reagents to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries in Sweden, Finland, Denmark, Norway, and internationally. The company operates through two segments, Labtech and Medtech. The Labtech segment provides analysis instruments, equipment, microscopes, consumables and reagents, as well as software support and technical services primarily to laboratories in medicine, research, academia, food, pharmaceutical, microbiology, clinical chemistry, coagulation, molecular biology, immunology, point-of-care testing, and veterinary diagnostics industries. This segment also offers training programs, seminars, and advisory services. The Medtech segment provides medical device products to surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare markets. AddLife AB (publ) was founded in 1906 and is headquartered in Stockholm, Sweden.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.add.life
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more